Buckle Up: DOJ Initiates Rulemaking to Reschedule Marijuana
FDA Law Blog
MAY 21, 2024
29, 2023) (“Basis”); NPRM at 44,603. DEA noted that “there is considerable variability in the cannabinoid concentrations and chemical constituency among marijuana samples and that the interpretation of clinical data related to marijuana is complicated.” NPRM at 44,607. Denial of Petition at 53,700-02; Denial of Petition at 53,779-81.
69 
Let's personalize your content